Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Enzo Biochem Price to Book Ratio 2006-2020 | ENZ

Historical price to book ratio values for Enzo Biochem (ENZ) over the last 10 years. The current price to book ratio for Enzo Biochem as of November 24, 2020 is 1.61.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Enzo Biochem Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2020-11-25 1.97 1.62
2020-07-31 2.38 $1.22 1.95
2020-04-30 3.02 $1.30 2.32
2020-01-31 2.51 $1.49 1.68
2019-10-31 3.16 $1.65 1.92
2019-07-31 3.91 $1.81 2.16
2019-04-30 3.47 $1.91 1.81
2019-01-31 3.76 $1.43 2.63
2018-10-31 3.32 $1.60 2.07
2018-07-31 4.42 $1.72 2.57
2018-04-30 6.00 $1.83 3.28
2018-01-31 7.36 $1.87 3.93
2017-10-31 9.85 $1.90 5.18
2017-07-31 10.85 $1.91 5.68
2017-04-30 8.80 $1.91 4.61
2017-01-31 6.68 $1.90 3.52
2016-10-31 6.10 $1.91 3.19
2016-07-31 6.97 $1.94 3.60
2016-04-30 4.98 $1.15 4.35
2016-01-31 4.74 $1.18 4.01
2015-10-31 3.72 $1.02 3.63
2015-07-31 3.00 $0.93 3.24
2015-04-30 2.80 $0.74 3.79
2015-01-31 3.15 $0.77 4.10
2014-10-31 5.22 $0.81 6.47
2014-07-31 4.80 $0.84 5.75
2014-04-30 4.20 $0.87 4.85
2014-01-31 2.81 $0.76 3.69
2013-10-31 2.49 $0.80 3.11
2013-07-31 2.18 $0.84 2.59
2013-04-30 2.24 $0.89 2.51
2013-01-31 2.89 $1.02 2.82
2012-10-31 2.00 $1.16 1.72
2012-07-31 1.50 $1.25 1.20
2012-04-30 2.74 $1.96 1.40
2012-01-31 2.55 $2.04 1.25
2011-10-31 2.86 $2.16 1.32
2011-07-31 3.84 $2.30 1.67
2011-04-30 3.99 $2.38 1.68
2011-01-31 4.96 $2.40 2.07
2010-10-31 4.31 $2.54 1.70
2010-07-31 4.60 $2.54 1.81
2010-04-30 5.97 $2.67 2.23
2010-01-31 4.74 $2.78 1.71
2009-10-31 5.51 $3.07 1.80
2009-07-31 5.10 $3.09 1.65
2009-04-30 4.10 $3.19 1.29
2009-01-31 4.89 $3.29 1.49
2008-10-31 5.77 $3.51 1.65
2008-07-31 14.21 $3.71 3.83
2008-04-30 8.18 $3.72 2.20
2008-01-31 9.36 $3.74 2.50
2007-10-31 12.11 $3.85 3.14
2007-07-31 12.78 $3.87 3.30
2007-04-30 16.81 $3.94 4.27
2007-01-31 14.84 $3.75 3.96
2006-10-31 14.30 $2.94 4.87
2006-07-31 12.89 $2.96 4.35
2006-04-30 12.28 $3.08 3.98
2006-01-31 13.04 $3.17 4.12
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.094B $0.076B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.106B 9.99
Amgen (AMGN) United States $129.370B 13.52
CSL (CSLLY) Australia $105.407B 0.00
Gilead Sciences (GILD) United States $75.074B 9.98
Vertex Pharmaceuticals (VRTX) United States $56.654B 26.34
Regeneron Pharmaceuticals (REGN) United States $55.872B 19.82
Illumina (ILMN) United States $44.070B 60.61
Moderna (MRNA) United States $39.979B 0.00
Biogen (BIIB) United States $37.452B 6.65
Seagen (SGEN) United States $30.304B 80.03
Alexion Pharmaceuticals (ALXN) United States $26.833B 10.69
BeiGene (BGNE) Cayman Islands $24.859B 0.00
BioNTech SE (BNTX) Germany $24.097B 0.00
Genmab (GMAB) Denmark $23.623B 27.94
Genmab (GNMSF) Denmark $22.573B 5.20
Exact Sciences (EXAS) United States $18.132B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Incyte (INCY) United States $17.824B 0.00
Bio-Rad Laboratories (BIO.B) United States $16.620B 63.03
Horizon Therapeutics Public (HZNP) Ireland $15.461B 22.10
Alnylam Pharmaceuticals (ALNY) United States $14.293B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.985B 92.82
ARGENX SE-ADR (ARGX) Netherlands $12.645B 0.00
Bio-Techne Corp (TECH) United States $11.727B 75.00
Guardant Health (GH) United States $11.408B 0.00
Mirati Therapeutics (MRTX) United States $11.313B 0.00
QIAGEN (QGEN) Netherlands $10.666B 24.01
Sarepta Therapeutics (SRPT) United States $10.613B 0.00
Repligen (RGEN) United States $9.780B 138.71
ACADIA Pharmaceuticals (ACAD) United States $8.559B 0.00
Ascendis Pharma (ASND) Denmark $8.465B 0.00
Galapagos (GLPG) Belgium $8.184B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.772B 0.00
Denali Therapeutics (DNLI) United States $7.463B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.001B 0.00
Acceleron Pharma (XLRN) United States $6.842B 0.00
Adaptive Biotechnologies (ADPT) United States $6.268B 0.00
Novavax (NVAX) United States $5.983B 0.00
Amicus Therapeutics (FOLD) United States $5.835B 0.00
Exelixis (EXEL) United States $5.705B 38.31
Reata Pharmaceuticals (RETA) United States $5.544B 0.00
Blueprint Medicines (BPMC) United States $5.504B 18.22
Halozyme Therapeutics (HALO) United States $5.410B 250.13
SWEDISH ORP BIO (BIOVF) Sweden $5.385B 14.71
Twist Bioscience (TWST) United States $5.234B 0.00
NeoGenomics (NEO) United States $5.071B 1522.33
Fate Therapeutics (FATE) United States $4.736B 0.00
China Biologic Products (CBPO) China $4.664B 27.69
Emergent Biosolutions (EBS) United States $4.222B 13.86
Insmed (INSM) United States $3.991B 0.00
Arena Pharmaceuticals (ARNA) United States $3.762B 0.00
Legend Biotech (LEGN) United States $3.667B 0.00
Vir Biotechnology (VIR) United States $3.555B 0.00
MorphoSys AG (MOR) Germany $3.534B 127.90
Deciphera Pharmaceuticals (DCPH) United States $3.511B 0.00
Eidos Therapeutics (EIDX) United States $3.290B 0.00
Seres Therapeutics (MCRB) United States $3.110B 0.00
Alkermes (ALKS) Ireland $2.901B 28.48
Bluebird Bio (BLUE) United States $2.836B 0.00
Global Blood Therapeutics (GBT) United States $2.672B 0.00
Beam Therapeutics (BEAM) United States $2.462B 0.00
I-Mab (IMAB) China $2.297B 0.00
Zymeworks (ZYME) Canada $2.136B 0.00
UniQure (QURE) Netherlands $2.069B 0.00
Intellia Therapeutics (NTLA) United States $2.025B 0.00
Intra-Cellular Therapies (ITCI) United States $2.009B 0.00
PHARMA MAR SA (PHMMF) Spain $1.949B 0.00
Viela Bio (VIE) United States $1.906B 0.00
Sorrento Therapeutics (SRNE) United States $1.901B 0.00
Mesoblast (MESO) Australia $1.855B 0.00
Editas Medicine (EDIT) United States $1.828B 0.00
Inovio Pharmaceuticals (INO) United States $1.758B 0.00
Amarin (AMRN) Ireland $1.744B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.716B 0.00
Arcus Biosciences (RCUS) United States $1.672B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.659B 0.00
Mersana Therapeutics (MRSN) United States $1.635B 0.00
NGM Biopharmaceuticals (NGM) United States $1.623B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Revance Therapeutics (RVNC) United States $1.563B 0.00
Alcobra (ARCT) United States $1.502B 0.00
Zealand Pharma (ZEAL) Denmark $1.438B 0.00
Sangamo Therapeutics (SGMO) United States $1.413B 0.00
Scholar Rock Holding (SRRK) United States $1.393B 0.00
Ligand Pharmaceuticals (LGND) United States $1.387B 35.94
Adverum Biotechnologies (ADVM) United States $1.362B 0.00
Coherus BioSciences (CHRS) United States $1.331B 8.80
Myriad Genetics (MYGN) United States $1.330B 0.00
Athenex (ATNX) United States $1.307B 0.00
REGENXBIO (RGNX) United States $1.290B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Heska (HSKA) United States $1.221B 0.00
Travere Therapeutics (TVTX) United States $1.207B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.170B 0.00
Epizyme (EPZM) United States $1.159B 0.00
Cytokineticsorporated (CYTK) United States $1.137B 0.00
Precigen (PGEN) United States $1.102B 0.00
Vericel (VCEL) United States $1.065B 0.00
Genetron Holdings (GTH) China $1.059B 0.00
Northwest Biotherapeutics (NWBO) United States $1.046B 0.00
Alector (ALEC) United States $1.036B 0.00
Codexis (CDXS) United States $1.030B 0.00
Pliant Therapeutics (PLRX) United States $1.024B 0.00
Morphic Holding (MORF) United States $0.960B 0.00
Arvinas (ARVN) United States $0.949B 0.00
Cellectis S.A (CLLS) France $0.939B 0.00
Castle Biosciences (CSTL) United States $0.939B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.924B 0.00
Frequency Therapeutics (FREQ) United States $0.920B 0.00
Compugen (CGEN) Israel $0.898B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.882B 0.00
NantKwest (NK) United States $0.855B 0.00
Protagonist Therapeutics (PTGX) United States $0.844B 0.00
Celldex Therapeutics (CLDX) United States $0.841B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
Cara Therapeutics (CARA) United States $0.747B 0.00
MiMedx (MDXG) United States $0.726B 0.00
MannKind (MNKD) United States $0.712B 0.00
Kadmon Holdings (KDMN) United States $0.693B 0.00
AnaptysBio (ANAB) United States $0.686B 0.00
Agenus (AGEN) United States $0.681B 0.00
Cardiff Oncology (CRDF) United States $0.676B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.668B 33.94
Five Prime Therapeutics (FPRX) United States $0.664B 0.00
VBI Vaccines (VBIV) United States $0.658B 0.00
Albireo Pharma (ALBO) United States $0.654B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.648B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Precision BioSciences (DTIL) United States $0.622B 0.00
Sutro Biopharma (STRO) United States $0.620B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.596B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.592B 0.00
Geron (GERN) United States $0.577B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.539B 0.00
IVERIC Bio (ISEE) United States $0.537B 0.00
Anika Therapeutics (ANIK) United States $0.528B 71.48
Avid Bioservices (CDMO) United States $0.507B 0.00
Forte Biosciences (FBRX) United States $0.503B 0.00
MeiraGTx Holdings (MGTX) United States $0.486B 0.00
Cel-Sci (CVM) United States $0.482B 0.00
Dynavax Technologies (DVAX) United States $0.463B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.462B 0.00
Merus (MRUS) Netherlands $0.462B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
Puma Biotechnology (PBYI) United States $0.458B 0.00
Amryt Pharma (AMYT) United Kingdom $0.446B 0.00
WAVE Life Sciences (WVE) Singapore $0.440B 0.00
Spero Therapeutics (SPRO) United States $0.432B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.432B 0.00
UROGEN PHARMA (URGN) United States $0.427B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.419B 0.00
Kala Pharmaceuticals (KALA) United States $0.413B 0.00
Starpharma Holdings (SPHRY) Australia $0.408B 0.00
Innate Pharma S.A (IPHA) France $0.396B 0.00
Affimed (AFMD) Germany $0.390B 0.00
BioDelivery Sciences (BDSI) United States $0.385B 18.14
Xenon Pharmaceuticals (XENE) Canada $0.384B 0.00
AC Immune SA (ACIU) Switzerland $0.378B 0.00
Trevena (TRVN) United States $0.377B 0.00
Clovis Oncology (CLVS) United States $0.369B 0.00
XOMA (XOMA) United States $0.364B 0.00
Cue Biopharma (CUE) United States $0.364B 0.00
Syros Pharmaceuticals (SYRS) United States $0.362B 0.00
Cellular Biomedicine (CBMG) United States $0.355B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.352B 0.00
ANI Pharmaceuticals (ANIP) United States $0.349B 8.87
Selecta Biosciences (SELB) United States $0.345B 0.00
CytomX Therapeutics (CTMX) United States $0.338B 0.00
Arbutus Biopharma (ABUS) United States $0.312B 0.00
Athersys (ATHX) United States $0.308B 0.00
DBV Technologies S.A (DBVT) France $0.300B 0.00
ChromaDex (CDXC) United States $0.297B 0.00
Kamada (KMDA) Israel $0.296B 13.83
PDL BioPharma (PDLI) United States $0.282B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.280B 0.00
NextCure (NXTC) United States $0.272B 0.00
IBio (IBIO) United States $0.268B 0.00
TELA Bio (TELA) United States $0.250B 0.00
Verastem (VSTM) United States $0.250B 0.00
Fortress Biotech (FBIO) United States $0.246B 0.00
Pluristem Therapeutics (PSTI) Israel $0.242B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
CorMedix Inc (CRMD) United States $0.236B 0.00
Aptinyx (APTX) United States $0.213B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.199B 0.00
Aptevo Therapeutics (APVO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Bellus Health (BLU) Canada $0.183B 0.00
GENFIT S.A (GNFT) France $0.181B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.180B 0.00
AquaBounty Technologies (AQB) United States $0.178B 0.00
Cerecor (CERC) United States $0.175B 0.00
ADMA Biologics Inc (ADMA) United States $0.172B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.172B 0.00
Nicox SA (NICXF) France $0.170B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.167B 0.00
Dyadic (DYAI) United States $0.164B 0.00
VolitionRX (VNRX) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.163B 0.00
Oncobiologics (OTLK) United States $0.160B 0.00
Checkpoint Therapeutics (CKPT) United States $0.158B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.158B 0.00
Idera Pharmaceuticals (IDRA) United States $0.149B 0.00
SESEN BIO, INC (SESN) United States $0.149B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Kindred Biosciences (KIN) United States $0.147B 0.00
VTv Therapeutics (VTVT) United States $0.142B 0.00
Lumos Pharma (LUMO) United States $0.138B 0.00
Abeona Therapeutics (ABEO) United States $0.136B 0.00
Protalix BioTherapeutics (PLX) Israel $0.128B 0.00
Celyad SA (CYAD) Belgium $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Exicure (XCUR) United States $0.125B 0.00
TRACON Pharmaceuticals (TCON) United States $0.124B 0.00
Gritstone Oncology (GRTS) United States $0.117B 0.00
Aytu Bioscience (AYTU) United States $0.116B 0.00
Liquidia Technologies (LQDA) United States $0.116B 0.00
Orgenesis (ORGS) United States $0.115B 238.50
Antibe Therapeutics (ATBPF) Canada $0.111B 0.00
Cogent Biosciences (COGT) United States $0.111B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Applied Genetic Technologies (AGTC) United States $0.111B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.108B 0.00
Cyclerion Therapeutics (CYCN) United States $0.106B 0.00
Prometic Life Sciences (LMNL) Canada $0.104B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Palatin Technologies (PTN) United States $0.099B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Novogen (KZIA) Australia $0.090B 0.00
ARAVIVE, INC (ARAV) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
Evogene (EVGN) Israel $0.082B 0.00
Curis (CRIS) United States $0.079B 0.00
DiaMedica Therapeutics (DMAC) United States $0.078B 0.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.077B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 32.50
MiRagen Therapeutics (MGEN) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
Soligenix (SNGX) United States $0.064B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Cocrystal Pharma (COCP) United States $0.060B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Organovo Holdings (ONVO) United States $0.059B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.054B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Edesa Biotech (EDSA) Canada $0.052B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Vaccinex (VCNX) United States $0.046B 0.00
Seelos Therapeutics (SEEL) United States $0.045B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.043B 0.00
IMMURON (IMRN) Australia $0.043B 0.00
Cleveland BioLabs (CBLI) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Pulmatrix (PULM) United States $0.039B 0.00
Titan Pharmaceuticals (TTNP) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.029B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
Celsion (CLSN) United States $0.020B 0.00
Spherix (AIKI) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
MedAvail Holdings (MDVL) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00